MétaCan
Menu
Retour à la cohorte
Enregistrement W2339603802 · doi:10.1016/s0022-2275(20)31539-x

Quantification of galactosylsphingosine in the twitcher mouse using electrospray ionization-tandem mass spectrometry

2001· article· en· W2339603802 sur OpenAlex
Phillip D. Whitfield, P. Sharp, Rosanne M. Taylor, Peter J. Meikle

Pourquoi ce travail est dans la base

Une base qui oublie comment elle a trouvé un travail ne peut pas être vérifiée. Voici les voies qui ont admis celui-ci.

aboutLe titre ou le résumé porte un signal canadien du lexique géographique.
no affAucune affiliation canadienne : ce travail est invisible pour une base fondée sur la seule affiliation.
Aucune affiliation canadienne. Une base fondée sur la seule affiliation (le devis habituel) n'aurait jamais vu ce travail. C'est l'un des travaux qui justifient l'inversion de la base.

Notice bibliographique

RevueJournal of Lipid Research · 2001
Typearticle
Langueen
DomaineMedicine
ThématiqueLysosomal Storage Disorders Research
Établissements canadiensnon disponible
Organismes subventionnairesnon disponible
Mots-clésTandem mass spectrometryChemistryElectrospray ionizationMass spectrometryProtein mass spectrometryChromatography

Résumé

récupéré en direct d'OpenAlex

Globoid cell leukodystrophy (Krabbe disease) is an autosomal recessive inherited neurodegenerative disorder caused by the deficiency of the lysosomal enzyme β-galactosylceramidase. The pathogenesis of the disorder has been proposed to arise from the accumulation of the cytotoxic metabolite galactosylsphingosine (psychosine). The twitcher mouse is a naturally occurring murine model of globoid cell leukodystrophy. We have developed a rapid, sensitive, and specific mass spectrometric method for determining the galactosylsphingosine concentration in the tissues of twitcher mice. Galactosylsphingosine is extracted from the tissues in methanol, isolated using strong cation-exchange and C18 solid-phase extraction chromatography, and then directly analyzed using electrospray ionization-tandem mass spectrometry. A lactosylsphingosine internal standard has been employed for quantification. The assay demonstrated significant accumulation of galactosylsphingosine in the brain, spinal cord, and kidney of twitcher mice. It is anticipated that this method may be of use in the monitoring of experimental therapies for globoid cell leukodystrophy.—Whitfield, P. D., P. C. Sharp, R. Taylor, and P. Meikle. Quantification of galactosylsphingosine in the twitcher mouse using electrospray ionization-tandem mass spectrometry. J. Lipid Res. 2001. 42: 2092–2095. Globoid cell leukodystrophy (Krabbe disease) is an autosomal recessive inherited neurodegenerative disorder caused by the deficiency of the lysosomal enzyme β-galactosylceramidase. The pathogenesis of the disorder has been proposed to arise from the accumulation of the cytotoxic metabolite galactosylsphingosine (psychosine). The twitcher mouse is a naturally occurring murine model of globoid cell leukodystrophy. We have developed a rapid, sensitive, and specific mass spectrometric method for determining the galactosylsphingosine concentration in the tissues of twitcher mice. Galactosylsphingosine is extracted from the tissues in methanol, isolated using strong cation-exchange and C18 solid-phase extraction chromatography, and then directly analyzed using electrospray ionization-tandem mass spectrometry. A lactosylsphingosine internal standard has been employed for quantification. The assay demonstrated significant accumulation of galactosylsphingosine in the brain, spinal cord, and kidney of twitcher mice. It is anticipated that this method may be of use in the monitoring of experimental therapies for globoid cell leukodystrophy. —Whitfield, P. D., P. C. Sharp, R. Taylor, and P. Meikle. Quantification of galactosylsphingosine in the twitcher mouse using electrospray ionization-tandem mass spectrometry. J. Lipid Res. 2001. 42: 2092–2095. Globoid cell leukodystrophy (Krabbe disease) is an autosomal recessive disorder caused by the deficiency of the lysosomal enzyme β-galactosylceramidase (EC 3.2.1.46) (1Suzuki K. Suzuki Y. Globoid cell leucodystrophy (Krabbe's disease): deficiency of galactocerebroside β-galactosidase.Proc. Natl. Acad. Sci. USA. 1970; 66: 302-309Google Scholar). The disease is characterized by the degeneration of oligodendroglia and progressive demyelination of the central and peripheral nervous system. Clinically, the disease manifests in early infancy and results in complete neurological dysfunction that often leads to death by 2 years of age (2Suzuki K. Suzuki Y. Suzuki K. Galactosylceramide lipidosis: globoid cell leukodystrophy (Krabbe disease).in: Scriver C.R. Beaudet A.L. Sly W.S. Valle D. The Metabolic and Molecular Basis of Inherited Disease. McGraw-Hill, New York1995: 2671-2692Google Scholar). In globoid cell leukodystrophy galactosylceramide, the primary natural substrate of the deficient enzyme does not accumulate in the tissues of affected individuals. Rather, the pathogenesis of the disease has been proposed to arise from the storage of a cytotoxic metabolite, galactosylsphingosine (psychosine), which is also a substrate for the missing enzyme (3Miyatake T. Suzuki K. Globoid cell leukodystrophy: additional deficiency of psychosine galactosidase.Biochim. Biophys. Acta. 1972; 48: 538-543Google Scholar). The twitcher mouse is an authentic murine model of globoid cell leukodystrophy that is genetically and enzymatically equivalent to the human form of the disease and displays similar pathological features (4Duchen L.W. Eicher E.M. Jacobs J.M. Scaravilli F. Teixira F. Hereditary leucodystrophy in the mouse: the new mutant twitcher.Brain. 1980; 103: 695-710Google Scholar, 5Kobayashi T. Yamanaka T. Jacobs J.M. Teixeira F. Suzuki K. The twitcher mouse: an enzymatically authentic model of human globoid cell leuckodystrophy (Krabbe disease).Brain Res. 1980; 202: 479-483Google Scholar). Studies have also demonstrated a marked accumulation of galactosylsphingosine in the brain and other tissues of twitcher mice (6Igisu H. Suzuki K. Progressive accumulation of toxic metabolite in a genetic leukodystrophy.Science. 1984; 224: 753-755Google Scholar, 7Kobayashi T. Shinoda H. Goto I. Yamanaka T. Suzuki Y. Globoid cell leukodystrophy is a generalized galactosylsphingosine (psychosine) storage disease.Biochim. Biophys. Acta. 1987; 144: 41-46Google Scholar, 8Shinoda H. Kobayashi T. Katayama M. Goto I. Nagara H. Accumulation of galactosylsphingosine (psychosine) in the twitcher mouse: determination by HPLC.J. Neurochem. 1987; 49: 92-99Google Scholar, 9Nozawa M. Iwamaoto T. Tokoro T. Eto Y. Novel procedure for measuring psychosine derivatives by an HPLC method.J. Neurochem. 1992; 59: 607-609Google Scholar). A number of methods previously have been employed for the analysis of galactosylsphingosine and related compounds from tissues (6Igisu H. Suzuki K. Progressive accumulation of toxic metabolite in a genetic leukodystrophy.Science. 1984; 224: 753-755Google Scholar, 7Kobayashi T. Shinoda H. Goto I. Yamanaka T. Suzuki Y. Globoid cell leukodystrophy is a generalized galactosylsphingosine (psychosine) storage disease.Biochim. Biophys. Acta. 1987; 144: 41-46Google Scholar, 8Shinoda H. Kobayashi T. Katayama M. Goto I. Nagara H. Accumulation of galactosylsphingosine (psychosine) in the twitcher mouse: determination by HPLC.J. Neurochem. 1987; 49: 92-99Google Scholar, 9Nozawa M. Iwamaoto T. Tokoro T. Eto Y. Novel procedure for measuring psychosine derivatives by an HPLC method.J. Neurochem. 1992; 59: 607-609Google Scholar, 10Svennerholm L. Vanier M-T. Mansson J-E. Krabbe disease: a galactosylsphingosine (psychosine) lipidosis.J. Lipid Res. 1980; 21: 53-64Google Scholar, 11Igisu H. Suzuki K. Analysis of galactosylsphingosine (psychosine) in the brain.J. Lipid Res. 1984; 25: 1000-1006Google Scholar, 12Orvisky E. Sidransky E. McKinney C.E. LaMarca M.E. Samimi R. Krasnewich D. Martin B.M. Ginns E.I. Glucosylsphingosine accumulation in mice and patients with type 2 gaucher disease begins early in gestation.Pediatr. Res. 2000; 48: 233-237Google Scholar). These methods have typically involved the solvent extraction of galactosylsphingosine, and then isolation and derivatization prior to detection by either TLC or HPLC. In recent years, mass spectrometers have become more common in metabolic laboratories and have been applied to the study of lysoglycosphingolipids (13Hara A. Taketomi T. Chemical properties of heterogenous long chain bases in lysosphingolipids by positive ion fast atom bombardment mass spectrometry and carbon-13 NMR spectroscopy.J. Biochem. 1986; 100: 415-423Google Scholar, 14Taketomi T. Hara A. Uemura K. Sugiyama E. Rapid method of preparation of lysoglycosphingolipids and their confirmation by delayed extraction matrix-assisted laser desorption ionization time-of-flight mass spectrometry.J. Biochem. 1996; 120: 573-579Google Scholar). In this study, we describe the development of a rapid, sensitive, and specific method using electrospray ionization-tandem mass spectrometry (ESI-MS/MS) to characterize and quantify underivatized galactosylsphingosine from the tissues of twitcher mice. Solvents were analytical grade. Galactosylsphingosine and lactosylsphingosine (lyso-lactosyl ceramide) were purchased from Matreya Inc. (Pleasant Gap, PA). [6-3H]galactosylsphingosine (psychosine, [galactose-6-3H]) was obtained from American Radiolabeled Chemicals, Inc. (St. Louis, MO) and used after purification. Supelclean™ strong cation-exchange (SCX) solid-phase extraction cartridges (sodium form, 500 mg/3 ml) were purchased from Supelco (Bellefonte, PA). Bond Elut® endcapped C18 solid-phase extraction cartridges (500 mg/6 ml) were purchased from Varian, Inc. (Harbor City, CA). A colony of twitcher mice was maintained under Animal Ethics Committee approval at the University of Sydney Veterinary School. The genetic status of individual mice was determined by PCR on DNA extracted from the clipped toe or tail at postnatal day 5. After the animals were decapitated, whole brain, spinal cord, liver, spleen, and kidney were dissected. Wet weights were measured and the tissues were then stored at −70 °C until use. A maximum of 100 mg of wet weight tissue was homogenized with an Ultra Turrax (IKA) T25 Basic mechanical homogenizer in 3 ml methanol. After a minimum of 1 h at room temperature, denatured solids were pelleted by centrifugation. Five nanomoles of lactosylsphingosine was added to the methanol extract supernatant as an internal standard (ISTD). Galactosylsphingosine was then isolated using a modified form of the method described by Igisu and Suzuki (11Igisu H. Suzuki K. Analysis of galactosylsphingosine (psychosine) in the brain.J. Lipid Res. 1984; 25: 1000-1006Google Scholar). A SCX solid-phase extraction cartridge (500 mg/3 ml) was washed with 3 ml methanol after which the methanol tissue extract was applied to the column. The column was then successively washed to waste with 5 ml methanol, 5 ml chloroform–methanol 2:1 (v/v), and 5 ml methanol. Cationic lipids were then eluted with 5 ml methanol–0.4 M CaCl2 3:1 (v/v). This eluate was then desalted using an endcapped C18 solid-phase extraction cartridge (500 mg/6 ml) that had been primed with 5 ml methanol followed by 5 ml distilled water. The methanol–0.4 M CaCl2 3:1 (v/v) fraction was then directly applied to the column after which the column was washed with 15 ml distilled water before elution of the galactosylsphingosine with 7.5 ml chloroform–methanol 1:2 (v/v). The chloroform–methanol 1:2 (v/v) fraction was dried under nitrogen gas with gentle heat and reconstituted in 100–200 μl methanol containing 5 mM ammonium formate. All mass spectrometric analyses were performed by ESI-MS/MS using a Perkin-Elmer Sciex API 365 triple-quadrupole mass spectrometer with an Ionspray source and LC Tune/Multiview data system (PE Sciex, Concord, Ontario, Canada). Galactosylsphingosine and the lactosylsphingosine ISTD were identified by precursor ion scanning for mass to charge ratio (m/z) 282 in the positive ion mode. Optimization of ESI-MS/MS parameters was achieved with 1 μM solutions of galactosylsphingosine and lactosylsphingosine. Tissues and calibration samples were directly infused into the electrospray source via a fused silica transfer line using a Harvard Apparatus syringe pump at a flow rate of 10 μl/min. Quantification of galactosylsphingosine was performed using the multiple-reaction monitoring (MRM) mode. For each quantitative measurement, the ions relating to galactosylsphingosine (m/z 462) and the lactosylsphingosine ISTD (m/z 624) were monitored for 100 ms each, and 100 consecutive scans were averaged. Galactosylsphingosine calibration curves were constructed by adding varying amounts of galactosylsphingosine standard (0–8 nmol) and a constant amount of the lactosylsphingosine (5 nmol) to the brain lipid extracts from normal mice (equivalent to 100 mg wet weight tissue), which were then carried through the entire isolation and purification procedure. The response ratio of the galactosylsphingosine to the ISTD was calculated, and the concentration of the galactosylsphingosine was determined by comparison to a calibration curve. Purified [6-3H]galactosylsphingosine was added to a lipid extract of a twitcher mouse brain that was equivalent to 100 mg wet weight tissue. Five nanomoles of the lactosylsphingosine ISTD was also added. The recovery of the [6-3H]galactosylsphingosine through the SCX and C18 isolation steps was then calculated. Recovery data were obtained from three repeat experiments, and the recovery was estimated to be 45–60%, a finding consistent with previous reports (8Shinoda H. Kobayashi T. Katayama M. Goto I. Nagara H. Accumulation of galactosylsphingosine (psychosine) in the twitcher mouse: determination by HPLC.J. Neurochem. 1987; 49: 92-99Google Scholar, 11Igisu H. Suzuki K. Analysis of galactosylsphingosine (psychosine) in the brain.J. Lipid Res. 1984; 25: 1000-1006Google Scholar). The free amino group of galactosylsphingosine ionizes very efficiently, making it highly amenable to analysis by ESI-MS/MS. In positive ion mode, collision-induced dissociation of galactosylsphingosine gave rise to a major product ion at m/z 282 and a minor product ion at m/z 264. These ions result from the loss of one or two water molecules from the sphingosine backbone, respectively, and the elimination of the galactose moiety. Lactosylsphingosine was found to fragment in an identical manner. Therefore, galactosylsphingosine and the ISTD were characterized by means of a precursor ion scan for m/z 282. Figure 1A shows the galactosylsphingosine profile from the brain of a control mouse obtained by ESI-MS/MS. Galactosylsphingosine (m/z 462) was barely detectable. The intense ion at m/z 624 corresponds to the lactosylsphingosine ISTD. In contrast, examination of the brain lipid extract from a twitcher mouse showed a marked accumulation of galactosylsphingosine (Fig. 1B). The mass spectrum was dominated by the [M +H]+ ion of galactosylsphingosine. The calibration curve of galactosylsphingosine was found to be linear over the range typically encountered in control and twitcher mice tissues (0–8 nmol, regression coefficient = 0.986). To access reproducibility of the complete assay from batch to batch, replicate analysis of a single lipid extract from a postmortum brain of a patient with globoid cell leukodystrophy was performed on 15 separate occasions. The interbatch coefficient of variation for the galactosylsphingosine concentration in the brain was 12.1%. In addition, the reproducibility of the assay within a batch was also assessed. Simultaneous analysis of the brain extract (n = 5) produced an intrabatch coefficient of variation of 4.1%. The reproducibility of the ESI-MS/MS was also examined. Five separate infusions of the same sample into the tandem mass spectrometry produced a coefficient of variation of 1.2%. The margin of error would be expected to be greater in control and somatic tissues where the concentration of galactosylsphingosine is extremely low. ESI-MS/MS analysis of galactosylsphingosine demonstrated a lower limit of detection of 1–5 ng/100 mg wet weight tissue. There was a significant accumulation of galactosylsphingosine in the liver, kidney, spleen, brain, and spinal cord of twitcher mice. A small quantity of galactosylsphingosine was also detected in the tissues of control mice. As previously reported in twitcher mice, the concentration of galactosylsphingosine was much greater in the nervous tissues than in the somatic organs (7Kobayashi T. Shinoda H. Goto I. Yamanaka T. Suzuki Y. Globoid cell leukodystrophy is a generalized galactosylsphingosine (psychosine) storage disease.Biochim. Biophys. Acta. 1987; 144: 41-46Google Scholar, 9Nozawa M. Iwamaoto T. Tokoro T. Eto Y. Novel procedure for measuring psychosine derivatives by an HPLC method.J. Neurochem. 1992; 59: 607-609Google Scholar). Among the somatic organs, the kidney accumulated larger amounts of galactosylsphingosine than the liver or spleen (Table 1).TABLE 1.Galactosylsphingosine concentration in somatic organs of twitcher miceTissueGalactosylsphingosine ConcentrationaSamples were analyzed from two twitcher mice and two control mice at postnatal day 40.ControlTwitcherng/100 mg wet weight tissueLiver665558Kidney759491Spleen10106047a Samples were analyzed from two twitcher mice and two control mice at postnatal day 40. Open table in a new tab In brain and spinal cord of twitcher mice, the accumulation of galactosylsphingosine increased with age (Table 2), a finding consistent with previous studies (6Igisu H. Suzuki K. Progressive accumulation of toxic metabolite in a genetic leukodystrophy.Science. 1984; 224: 753-755Google Scholar, 8Shinoda H. Kobayashi T. Katayama M. Goto I. Nagara H. Accumulation of galactosylsphingosine (psychosine) in the twitcher mouse: determination by HPLC.J. Neurochem. 1987; 49: 92-99Google Scholar). The absolute concentrations of galactosylsphingosine were greatest in the spinal cord; however, interestingly, between the ages of 25 and 40 days, the rate of accumulation of galactosylsphingosine was highest in the brain of the twitcher mice (Table 2).TABLE 2.Galactosylsphingosine concentration in the central nervous system of twitcher miceDays After BirthGalactosylsphingosine ConcentrationaGalactosylsphingosine was analyzed from two twitcher and two control mice of various ages.BrainSpinal CordControlTwitcherControlTwitcherng/100 mg wet weight tissue257674995484679848415430—bNot determined.1313—5800—1030—609335—1489—7092—1201—48374015124312255421115471087739a Galactosylsphingosine was analyzed from two twitcher and two control mice of various ages.b Not determined. Open table in a new tab The determination of galactosylsphingosine in tissues of twitcher mice was originally described by Igisu and Suzuki (11Igisu H. Suzuki K. Analysis of galactosylsphingosine (psychosine) in the brain.J. Lipid Res. 1984; 25: 1000-1006Google Scholar). Their elegant method made use of SCX and C18 reverse-phase chromatography to isolate galactosylsphingosine after tissue lipid extraction. The galactosylsphingosine was then derivatized, chromatographed on thin-layer plates, and detected using fluorescence densitometry.In later studies, derivatized galactosylsphingosine was detected by HPLC (7Kobayashi T. Shinoda H. Goto I. Yamanaka T. Suzuki Y. Globoid cell leukodystrophy is a generalized galactosylsphingosine (psychosine) storage disease.Biochim. Biophys. Acta. 1987; 144: 41-46Google Scholar, 8Shinoda H. Kobayashi T. Katayama M. Goto I. Nagara H. Accumulation of galactosylsphingosine (psychosine) in the twitcher mouse: determination by HPLC.J. Neurochem. 1987; 49: 92-99Google Scholar, 9Nozawa M. Iwamaoto T. Tokoro T. Eto Y. Novel procedure for measuring psychosine derivatives by an HPLC method.J. Neurochem. 1992; 59: 607-609Google Scholar). To the best of the authors' knowledge, this is the first report of the quantification of galactosylsphingosine using ESI-MS/MS. This procedure is rapid, selective, reproducible, and sensitive. In our method, we adapted and simplified the original isolation procedures. These improvements enable larger numbers of tissues to be prepared more rapidly than conventional procedures. We removed the need for a time-consuming postextraction rotary evaporation step, and made use of commercially available solid-phase extraction cartridges. Furthermore, we took advantage of the selectivity and sensitivity of ESI-MS/MS to detect galactosylsphingosine, eliminating the need for derivatization. This need for sensitivity is vital because even in the disease state, the absolute amount of galactosylsphingosine that accumulates in tissues is very small. For analysis, we routinely isolated galactosylsphingosine from 100 mg wet weight neural or somatic tissues for both control and twitcher mice. However, for twitcher mice brain and spinal cord, considerably smaller quantities of tissue could be reliably used. Classical methods of lipid extraction such as the method of Folch et al. (15Folch J. Lees M. Sloane Stanley G.H. A simple method for the isolation and purification of total lipids from animal tissues.J. Biol. Chem. 1957; 226: 497-509Google Scholar) are unable to partition galactosylsphingosine into either the chloroform or methanol/water phase. As a result, it is necessary to isolate galactosylsphingosine from all tissue components including other bulk lipids, using the specificity of SCX chromatography. We used commercially available SCX solid-phase extraction columns (sodium form). These cartridges avoided the problems typically associated with the preparation of ion exchange resins, such as variable packing and and were found to highly of galactosylsphingosine from twitcher mouse For the isolation of galactosylsphingosine, it is to lipid extracts to SCX columns in methanol. The of significant quantities of chloroform water in the extraction has been reported to result in of galactosylsphingosine from SCX columns (11Igisu H. Suzuki K. Analysis of galactosylsphingosine (psychosine) in the brain.J. Lipid Res. 1984; 25: 1000-1006Google Scholar). studies (8Shinoda H. Kobayashi T. Katayama M. Goto I. Nagara H. Accumulation of galactosylsphingosine (psychosine) in the twitcher mouse: determination by HPLC.J. Neurochem. 1987; 49: 92-99Google Scholar, 9Nozawa M. Iwamaoto T. Tokoro T. Eto Y. Novel procedure for measuring psychosine derivatives by an HPLC method.J. Neurochem. 1992; 59: 607-609Google Scholar) have typically involved the tissues with water followed by solvent extraction with chloroform–methanol 2:1 (v/v). The water and are then to using a rotary In this study, we found that galactosylsphingosine was extracted from twitcher tissues into methanol. demonstrated that chloroform–methanol 2:1 (v/v) not extract more galactosylsphingosine from twitcher mouse tissues than methanol. In addition, our the finding of Igisu and Suzuki (11Igisu H. Suzuki K. Analysis of galactosylsphingosine (psychosine) in the brain.J. Lipid Res. 1984; 25: 1000-1006Google Scholar) that the of the total lipid sample was for the of psychosine on the SCX amounts of galactosylsphingosine were found to through the SCX column the lipids extracted from more than 100 mg wet weight tissues were applied not Quantification of the galactosylsphingosine was achieved by the use of commercially available lactosylsphingosine as an which was added at the extraction to for the This was found to in a similar to galactosylsphingosine both the extraction and purification procedure and analyzed by ESI-MS/MS. However, to the in the ionization it was found that the of concentration of galactosylsphingosine was typically greater than that of the lactosylsphingosine ISTD. We that this from the of the lactosylsphingosine. a of galactosylsphingosine would have been used as an this is not commercially available and is to of laboratories J.M. of and Chem. 2000; Scholar). demonstrated that the highest concentrations of galactosylsphingosine were in the brain and spinal cord of the twitcher mice. The absolute concentrations of galactosylsphingosine in the neural tissues were found to be in with determined by conventional HPLC methods (7Kobayashi T. Shinoda H. Goto I. Yamanaka T. Suzuki Y. Globoid cell leukodystrophy is a generalized galactosylsphingosine (psychosine) storage disease.Biochim. Biophys. Acta. 1987; 144: 41-46Google Scholar, 8Shinoda H. Kobayashi T. Katayama M. Goto I. Nagara H. Accumulation of galactosylsphingosine (psychosine) in the twitcher mouse: determination by HPLC.J. Neurochem. 1987; 49: 92-99Google Scholar, 9Nozawa M. Iwamaoto T. Tokoro T. Eto Y. Novel procedure for measuring psychosine derivatives by an HPLC method.J. Neurochem. 1992; 59: 607-609Google Scholar). A in galactosylsphingosine accumulation in the brain and spinal cord of the mice with age was also The of galactosylsphingosine accumulation was found to be greater in brain than in spinal cord of twitcher mice (Table In we described a tandem mass spectrometric method for the quantification of galactosylsphingosine in the tissues of twitcher mice. It is anticipated that this method could be employed to a range of lysoglycosphingolipids in various including In addition, this method could be developed to galactosylsphingosine in or to the of therapies developed for globoid cell leukodystrophy. for a The also to for the and of the mice and for electrospray ionization-tandem mass spectrometry internal standard multiple-reaction monitoring mass to charge ratio strong cation-exchange

Récupéré en direct depuis OpenAlex et désinversé. Les résumés ne sont pas conservés dans cette base de données : les index inversés représentent 8,6 Go des 9,3 Go de texte de la base, et le serveur dispose de 13 Go libres.

Prédiction distillée sur la base complète

Imitation des enseignants

Ni prévalence calibrée, ni vérité terrain. Validation humaine à venir. Apprise à partir de 10 348 étiquettes directes de Codex et de 10 348 étiquettes directes de Gemma. Le mode candidate est l'union des têtes enseignantes seuillées; le consensus est leur intersection. Ces sorties portent le statut machine_predicted_unvalidated et ne sont ni des étiquettes humaines ni des étiquettes directes de modèles de pointe.

score de la tête « metaresearch » (Codex)0,006
score de la tête « metaresearch » (Gemma)0,002
Version: codex-gemma-dda1882f352aStatut de validation: machine_predicted_unvalidated
Catégories candidatesaucune
Catégories consensuellesaucune
DomaineSignal candidat: aucune · Signal consensuel: aucune
Devis d'étudeSignal candidat: Expérimental (laboratoire) · Signal consensuel: aucune
GenreSignal candidat: Empirique · Signal consensuel: Empirique
Score de désaccord entre enseignants0,417
Score d'incertitude au seuil0,586

Scores Codex et Gemma par catégorie

CatégorieCodexGemma
Métarecherche0,0060,002
Méta-épidémiologie (sens strict)0,0000,000
Méta-épidémiologie (sens large)0,0000,000
Bibliométrie0,0010,003
Études des sciences et des technologies0,0000,000
Communication savante0,0000,000
Science ouverte0,0000,000
Intégrité de la recherche0,0000,001
Charge utile insuffisante (le modèle a refusé de juger)0,0000,000

Scores machine (provisoires)

Les deux têtes enseignantes du modèle étudiant, lues sur ce travail. Un score ordonne la base pour la relecture; il n'affirme jamais une catégorie, et le statut de validation accompagne chaque rangée tel quel.

Scores de référence d'un modèle non mature (critères de maturité non atteints, 7 itérations). Un score ordonne; il n'affirme jamais une catégorie.

Tête enseignante Opus0,110
Tête enseignante GPT0,408
Écart entre enseignants0,299 · la distance entre les deux têtes enseignantes sur ce seul travail
Statut de validationscore_only:v0-immature-baseline · tel quel depuis la passe de notation : score_only signifie que le nombre peut ordonner les travaux, et qu'aucune étiquette de catégorie n'en découle